Events

Find VeraSci at these Conferences and Events

AD/PD | The 14th International Conference on Alzheimer’s & Parkinson’s Disease

Lisbon Portugal | March 26th-31st 2019

We invite you to join us at the upcoming 14th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders. The groundbreaking series of Alzheimer’s and Parkinson’s Diseases Conferences attract international medical and scientific professionals worldwide. The Conference is at the forefront of unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s and […]

Read More

SIRS | Congress of the Schizophrenia International Research Society

Orlando, FL | April 10th-14th 2019

The Schizophrenia International Society’s (SIRS) Board of Directors is thrilled to announce that moving forward the society will host annual meetings.  Partnering with the International Congress on Schizophrenia Research (ICOSR), SIRS is working to create a cohesive balance incorporating key individuals and elements from both the legacy of ICOSR and SIRS.  The annual meeting is […]

Read More

AAN | American Academy of Neurology 2019 Annual Meeting

Philadelphia, PA | May 4th-10th 2019

The 2019 AAN Annual Meeting offers innovative, unique, and creative experiences throughout the week served up in exciting and inspirational formats to fuel your mind, body, and spirit.

Read More

AARR | Alzheimer’s Association Research Roundtable Spring Meeting

Washington, DC | May 21st-22nd 2019

The mission of the Alzheimer’s Association Research Roundtable (AARR) is to advance the research, development and management of new treatments for Alzheimer’s disease. The AARR member companies provide leadership and direction to the organization’s various activities. Begun in 2003 with four members, the Research Roundtable now includes more than 20 corporate members, whose scientists participate […]

Read More

ASCP | American Society for Clinical Psychopharmacology

Phoenix, AZ | May 28th-31st 2019

The ASCP Annual Meeting, organized by the American Society of Clinical Psychopharmacology will take place from 27th May to 31st May 2019 at the Fairmont Scottsdale Princess in Scottsdale, United States Of America. The conference will provide the opportunity to present and hear new findings many of which can impact the care of patients now.

Read More

ASCO | 55th Annual Meeting of the American Society of Clinical Oncology

Chicago, IL | May 31st-June 4th 2019

ASCO 2019, 55th Annual Meeting of the American Society of Clinical Oncology will be conducted between 31 May and 04 Jun 2019 at Chicago, Illinois USA. It’s regarding Medical, Health, Breast Cancer, Oncology, Cancer, Medical Oncology, Cancer Treatment, Immunotherapy, Colorectal Cancer, Skin Cancer, Cancer Prevention, Melanoma, Pediatric Oncology, Gynecologic Cancer and Tumor Biology. The guides […]

Read More

NDD | Neuropsychiatric Drug Development Summit

Boston, MA | July 2nd-3rd 2019

With an emphasis on depressive disorders, this industry focused forum will allow you to explore novel targets and mechanisms of action, address factors for mitigating and eliminating risk in clinical trials and evaluate the preclinical and clinical biomarker landscape to more robustly translate preclinical results in the clinic. Join your peers at NDD to be part of the […]

Read More

AAIC | Alzheimer’s Association International Conference

Los Angeles, CA | July 14th-18th 2019

The Alzheimer’s Association International Conference® (AAIC®) is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next generation investigators, clinicians and the care research community to share research discoveries that will lead to methods of prevention and treatment, and improvements […]

Read More

ISCTM | International Society for CNS Clinical Trials and Methodology Fall Meeting

Copenhagen Denmark | September 5th-7th 2019

The International Society for CNS Clinical Trials and Methodology (ISCTM) is a multi-disciplinary independent organization, devoted to promoting advances that address strategic clinical, regulatory, methodological and policy challenges that arise in the development and use of CNS therapeutic agents. This work is accomplished through partnership with persons in academia, industry, government, policy-making, and the public.

Read More

CNS Summit | 10th Annual Meeting

Boca Raton, FL | October 31st-November 3rd 2019

CNS Summit is a platform for change and a community passionate about shaping the future, with a focus on collaboration, innovation, and technology. Our mission is to have a positive impact on the success of clinical development programs. We believe this mission is our ethical duty to the patients we serve by developing new treatments. If […]

Read More

AARR | Alzheimer’s Association Reasearch Roundtable Fall Meeting

Washington, DC | November 19th-20th 2019

The mission of the Alzheimer’s Association Research Roundtable (AARR) is to advance the research, development and management of new treatments for Alzheimer’s disease. The AARR member companies provide leadership and direction to the organization’s various activities. Begun in 2003 with four members, the Research Roundtable now includes more than 20 corporate members, whose scientists participate […]

Read More

CTAD | Clinical Trials in Alzheimer’s Disease

San Diego, CA | December 4th-7th 2019

The development of the next generation of Alzheimer’s disease treatments is among the most important health needs worldwide, but presents huge challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the […]

Read More

ACNP | American College of Neuropsychopharmacology

Orlando, FL | December 8th-11th 2019

The Annual Meeting is one of the world’s leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs. The Annual Meeting provides an opportunity to: • Attend an outstanding scientific program in clinical and basic research on brain behavior-drug interactions. • Learn about the most recent and often unpublished advances in psychopharmacology. […]

Read More